Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.
about
Neural substrates of cue reactivity: association with treatment outcomes and relapseThe Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.Neuroimaging the Effectiveness of Substance Use Disorder Treatments.Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers.Pharmacological Options for Smoking Cessation in Heavy-Drinking SmokersEffects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers.Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokersEndogenous opioid system: a promising target for future smoking cessation medications.The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans.Pharmacotherapy of alcoholism - an update on approved and off-label medications.The Effect of Varenicline on the Neural Processing of Fearful Faces and the Subjective Effects of Alcohol in Heavy Drinkers.Transcranial magnetic stimulation of the dorsal lateral prefrontal cortex inhibits medial orbitofrontal activity in smokers.Cue-Induced Brain Activation in Chronic Ketamine-Dependent Subjects, Cigarette Smokers, and Healthy Controls: A Task Functional Magnetic Resonance Imaging Study.A Combination of Naltrexone + Varenicline Retards the Expression of a Genetic Predisposition Toward High Alcohol Drinking.Functional brain activation changes associated with practice in delaying smoking among moderate to heavy smokers: study protocol and rationale of a randomized trial (COPE)
P2860
Q26782278-CDFE56FF-C545-4BE6-8F90-EDC6F4A6EF12Q27310644-2D52D5D7-0069-4A0D-82B3-C81C52490C71Q31096451-401E25E8-3CB2-42B6-B27D-7A6CF54CCB99Q35689017-4A0D43B0-761F-4B8A-96CD-4158DD1A1D0FQ36294656-131B0436-23A7-4760-9F08-80649E76DDBEQ36363819-E1335C2D-C288-4634-8F9E-8C38173B6718Q36877440-0D1CE053-A08F-4F51-B406-63B62FBA3835Q38747115-122EE6BE-8EFD-44CE-AC33-B18EB4A3DE42Q42701015-C8E36BB2-D6FB-4459-8FC5-EC80D39123B1Q43061723-64B934B2-6163-462B-AED6-21BF013F0700Q47442429-AF48D148-8F6D-4A66-9631-6E51ACD75A44Q47642738-B9A4AA4E-F9FF-4AEB-9C51-830455F99007Q53417893-0A7C7995-B479-46C7-9E70-F88853301199Q54998102-85BA3B35-6EB2-404A-BD09-6FF2EC8F4A7FQ59127593-BFA01910-EF37-4D7D-8B52-50183169F14E
P2860
Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Varenicline, naltrexone, and t ...... iminary neuroimaging findings.
@ast
Varenicline, naltrexone, and t ...... iminary neuroimaging findings.
@en
type
label
Varenicline, naltrexone, and t ...... iminary neuroimaging findings.
@ast
Varenicline, naltrexone, and t ...... iminary neuroimaging findings.
@en
prefLabel
Varenicline, naltrexone, and t ...... iminary neuroimaging findings.
@ast
Varenicline, naltrexone, and t ...... iminary neuroimaging findings.
@en
P2093
P2860
P921
P1476
Varenicline, naltrexone, and t ...... liminary neuroimaging findings
@en
P2093
Arthur Brody
Dara G Ghahremani
Edythe D London
Karen Miotto
Lara A Ray
P2860
P356
10.3109/00952990.2014.927881
P577
2014-06-20T00:00:00Z